Latest & greatest articles for dementia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on dementia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on dementia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for dementia

1. Advance care planning for people living with dementia: An umbrella review of effectiveness and experiences Full Text available with Trip Pro

Advance care planning for people living with dementia: An umbrella review of effectiveness and experiences Advance Care Planning for People Living With Dementia: An Umbrella Review of Effectiveness and Experiences - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library of Medicine National (...) RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Review Int J Nurs Stud Actions . 2020 Jul;107:103576. doi: 10.1016/j.ijnurstu.2020.103576. Epub 2020 Mar 20. Advance Care Planning for People Living With Dementia: An Umbrella Review of Effectiveness and Experiences , , , , , Affiliations Expand Affiliations 1 End-of-Life Care Research Group, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090 Brussels, Belgium. Electronic address: Annelien.van.dael@vub.be. 2 Centre

2020 EvidenceUpdates

2. End of Life Care in Frailty: Dementia

End of Life Care in Frailty: Dementia End of Life Care in Frailty: Dementia | British Geriatrics Society Toggle main menu visibility Search Search Search Resources (menu position rule) Date Published: 12 May 2020 Last updated: 12 May 2020 The aim of this guidance series is to support clinicians and others to consider the needs of frail older people as they move towards the end of their lives and help them to provide high quality care. This chapter addresses specific issues which may arise (...) in people living with dementia towards the end of life. Please to view the other chapters in this series. Dementia is a condition that kills. According to one study, 1 the average life expectancy from diagnosis to death is 4.5 years, and average survival rate in this study varied from a high of 10.7 years for the youngest patients (65-69 years) to a 3.8 years for the people diagnosed after their 90 th birthday. People may die with dementia because of the dementia itself (which may lead to poor mobility

2020 British Geriatrics Society

3. Cognitive training interventions and depression in mild cognitive impairment and dementia: a systematic review and meta-analysis of randomized controlled trials

Cognitive training interventions and depression in mild cognitive impairment and dementia: a systematic review and meta-analysis of randomized controlled trials Cognitive Training Interventions and Depression in Mild Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced (...) citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Age Ageing Actions . 2020 May 6;afaa063. doi: 10.1093/ageing/afaa063. Online ahead of print. Cognitive Training Interventions and Depression in Mild Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , , , , , Affiliations Expand Affiliations 1 Department

2020 EvidenceUpdates

4. Effectiveness of different post-diagnostic dementia care models delivered by primary care: a systematic review

Effectiveness of different post-diagnostic dementia care models delivered by primary care: a systematic review Effectiveness of Different Post-Diagnostic Dementia Care Models Delivered by Primary Care: A Systematic Review - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library of Medicine (...) displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Br J Gen Pract Actions . 2020 May 28;70(695):e434-e441. doi: 10.3399/bjgp20X710165. Print 2020 Jun. Effectiveness of Different Post-Diagnostic Dementia Care Models Delivered by Primary Care: A Systematic Review , , , , , , , , , , , Affiliations Expand Affiliations 1 Department of Primary Care and Population Health, University College London, London, UK. 2 Saw Swee Hock School of Public Health, National

2020 EvidenceUpdates

5. Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline Full Text available with Trip Pro

Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline Randomized Placebo-Controlled Trial of the Effects of Aspirin on Dementia and Cognitive Decline - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library of Medicine National Center for Biotechnology (...) Actions Cite Share Permalink Copy Page navigation Neurology Actions . 2020 Mar 25;10.1212/WNL.0000000000009277. doi: 10.1212/WNL.0000000000009277. Online ahead of print. Randomized Placebo-Controlled Trial of the Effects of Aspirin on Dementia and Cognitive Decline , , , , , , , , , , , , , , , , , , Affiliations Expand Affiliations 1 From the School of Public Health and Preventive Medicine (J.R., E.S., R.L.W., R.W., C.M.R., S.A.W., J.E.L., S.G.O., R.T., J.J.M.) and the Turner Institute for Brain

2020 EvidenceUpdates

6. Association of Blood Pressure Lowering With Incident Dementia or Cognitive Impairment: A Systematic Review and Meta-analysis. (Abstract)

Association of Blood Pressure Lowering With Incident Dementia or Cognitive Impairment: A Systematic Review and Meta-analysis. The benefit of blood pressure lowering for the prevention of dementia or cognitive impairment is unclear.To determine the association of blood pressure lowering with dementia or cognitive impairment.Search of PubMed, EMBASE, and CENTRAL for randomized clinical trials published from database inception through December 31, 2019, that evaluated the association of blood (...) pressure lowering on cognitive outcomes. The control groups consisted of either placebo, alternative antihypertensive agents, or higher blood pressure targets.Data were screened and extracted independently by 2 authors. Random-effects meta-analysis models were used to report pooled treatment effects and CIs.The primary outcome was dementia or cognitive impairment. The secondary outcomes were cognitive decline and changes in cognitive test scores.Fourteen randomized clinical trials were eligible

2020 JAMA

7. Covid-19: Dementia and cognitive disorders

Covid-19: Dementia and cognitive disorders Dementia Scientific Panel Report - COVID-19 - eanpages COVID-19 May 13, 2020 COVID-19 May 13, 2020 COVID-19 May 6, 2020 COVID-19 May 6, 2020 COVID-19 May 13, 2020 COVID-19 May 13, 2020 COVID-19 May 6, 2020 COVID-19 May 6, 2020 Executive Page May 1, 2020 Executive Page April 1, 2020 Executive Page March 1, 2020 Executive Page February 1, 2020 Country of the Month May 1, 2020 Country of the Month April 5, 2020 Country of the Month March 1, 2020 Country (...) January 3, 2020 Patients societies reports January 2, 2020 Surveys April 10, 2020 Surveys October 7, 2019 Forum April 1, 2016 Forum March 1, 2016 Forum March 1, 2016 Forum February 1, 2016 Uncategorized May 2, 2020 Uncategorized May 1, 2020 Uncategorized May 1, 2020 Uncategorized April 29, 2020 Dementia Scientific Panel Report – COVID-19 April 3, 2020 During the Covid-19 pandemic, most European countries have imposed personal restrictions on their populations in order to inhibit viral transmission

2020 European Academy of Neurology

8. Diagnosis and Treatment of Clinical Alzheimer’s-Type Dementia

Diagnosis and Treatment of Clinical Alzheimer’s-Type Dementia Diagnosis and Treatment of Clinical Alzheimer’s-Type Dementia: A Systematic Review Comparative Effectiveness Review Number 223 RComparative Effectiveness Review Number 223 Diagnosis and Treatment of Clinical Alzheimer’s-Type Dementia: A Systematic Review Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov Contract No. 290-2015-00008-I (...) , M.F.A. Nancy L. Greer, Ph.D. Kerry M. Sheets, M.D. Timothy J. Wilt, M.D., M.P.H. Mary Butler, Ph.D., M.B.A. AHRQ Publication No. 20-EHC003 April 2020 Key Messages Purpose of Review To summarize evidence on cognitive test accuracy for clinical Alzheimer’s-type dementia (CATD) in suspected cognitive impairment; biomarker accuracy for Alzheimer’s disease (AD) in dementia; and effects of CATD drug treatment. Key Messages • Many brief cognitive tests were highly (>0.8) sensitive and specific

2020 Effective Health Care Program (AHRQ)

9. Covid-19: ALS and frontotemporal dementia

Covid-19: ALS and frontotemporal dementia Amyotrophic Lateral Sclerosis and COVID-19 – Recommendations to patients and caregivers - eanpages COVID-19 May 13, 2020 COVID-19 May 13, 2020 COVID-19 May 6, 2020 COVID-19 May 6, 2020 COVID-19 May 13, 2020 COVID-19 May 13, 2020 COVID-19 May 6, 2020 COVID-19 May 6, 2020 Executive Page May 1, 2020 Executive Page April 1, 2020 Executive Page March 1, 2020 Executive Page February 1, 2020 Country of the Month May 1, 2020 Country of the Month April 5, 2020 (...) (ALS), the impact of respiratory infections is expected to be more serious than in the general population, due to the weakness of the respiratory muscles and limitations in coughing (1-4). ALS patients with impaired respiratory function and/or rapid clinical deterioration are considered a high risk population for COVID-19 (5), even if no estimates in the different European countries are available. ENCALS centres and the EAN panel on ALS and Frontotemporal Dementia are working together across

2020 European Academy of Neurology

10. Covid-19: Advice for aged care providers – residents with dementia

Covid-19: Advice for aged care providers – residents with dementia Advice for aged care providers – residents with dementia 27 APRIL 2020 This advice provides information that may help to: i. reduce transmission of COVID-19 from resident to resident in aged residential care ii. maintain care and quality of life for residents with dementia or cognitive impairment. This advice is additional to, and should be read alongside, other guidance provided for health professionals and specifically (...) for aged residential care, which can be found on health.govt.nz/covid-19. Preventing COVID-19 in residents with dementia COVID-19 is highly contagious. We recognise that social distancing for residents with dementia may be difficult to maintain, and may heighten their anxiety and agitation. Increased staffing may be needed. You and your staff are in a good position to manage the care and wellbeing of your residents with dementia. This includes thinking about, preparing and communicating with residents

2020 Covid-19 Ad hoc guidelines

11. Family Identification of Delirium in the Emergency Department in Patients With and Without Dementia: Validity of the Family Confusion Assessment Method (FAM-CAM)

Family Identification of Delirium in the Emergency Department in Patients With and Without Dementia: Validity of the Family Confusion Assessment Method (FAM-CAM) Family Identification of Delirium in the Emergency Department in Patients With and Without Dementia: Validity of the Family Confusion Assessment Method (FAM-CAM) - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced (...) citation management software Create file Cancel Actions Cite Share Permalink Copy Page navigation J Am Geriatr Soc Actions . 2020 Apr 10. doi: 10.1111/jgs.16438. Online ahead of print. Family Identification of Delirium in the Emergency Department in Patients With and Without Dementia: Validity of the Family Confusion Assessment Method (FAM-CAM) , , , , , Affiliations Expand Affiliations 1 Department of Pharmacy and Health System Sciences, Northeastern University, Boston, Massachusetts, USA. 2

2020 EvidenceUpdates

12. Risperidone: Revised PBS restrictions for behavioural and psychological symptoms of dementia

Risperidone: Revised PBS restrictions for behavioural and psychological symptoms of dementia Risperidone: Revised PBS restrictions for behavioural and psychological symptoms of dementia - NPS MedicineWise Log In Menu During the COVID-19 pandemic, you need to continue to take your usual medicines and stay as healthy as possible. Here is some important information for everyone to keep in mind. Featured topics 30 Mar 2020 30 Mar 2020 30 Mar 2020 Featured article Information for consumers about (...) information for Australian health professionals and consumers. Featured resources 19 February 2020 19 February 2020 8 January 2020 Featured topic 20 years of helping Australians make better decisions about medicines, medical tests and other health technologies Partner with us Latest projects Search Search Search Search POPULAR Log in Log in All fields are required Email address* Password* Log in Risperidone: Revised PBS restrictions for behavioural and psychological symptoms of dementia PBS listings

2020 National Prescribing Service Limited (Australia)

13. Dementia and psychotropic medicines

Dementia and psychotropic medicines Reviewing and tapering antipsychotic medicines for BPSD Resident name: Referring health professional: Reviewing GP: Section 1: Current management Completed by the referring health professional on / / Concerning behaviours Non-pharmacological interventions Behaviour targeted by pharmacotherapy Antipsychotic medicine Dose/frequency Duration Prescriber Last reviewed / / Reason for review Antipsychotic medicine has been used for at least 12 weeks without (...) information on appropriate tools for monitoring BPSD including the NPI, visit the Dementia Outcomes Measurement Suite (DOMS) on the DementiaKT website at www.dementiakt.com.au/doms Tapering an antipsychotic medicine 1,3 STEP 1 To begin tapering, reduce the dose by 25-50% every 2 weeks. STEP 2 Monitor weekly while tapering and record observed changes in behaviour. STEP 3 If the target behaviours recur at any point during tapering, consider increasing to the previous lowest effective dose. STEP 4 Stop

2020 National Prescribing Service Limited (Australia)

14. Activities delivered at home by family carers to maintain cognitive function in people with dementia socially isolating during COVID-19: Evidence for Non – technology based activities / interventions

Activities delivered at home by family carers to maintain cognitive function in people with dementia socially isolating during COVID-19: Evidence for Non – technology based activities / interventions Activities delivered at home by family carers to maintain cognitive function in people with dementia socially isolating during COVID-19: Evidence for Non – technology based activities / interventions - CEBM CEBM The Centre for Evidence-Based Medicine develops, promotes and disseminates better (...) evidence for healthcare. Navigate this website Activities delivered at home by family carers to maintain cognitive function in people with dementia socially isolating during COVID-19: Evidence for Non – technology based activities / interventions May 7, 2020 Mari Lloyd-Williams, Caroline Mogan, Sarah Russell, Karen Harrison-Dening Academic Palliative and Supportive Care Studies Group, University of Liverpool On behalf of the Oxford COVID-19 Evidence Service Team Centre for Evidence-Based Medicine

2020 Oxford COVID-19 Evidence Service

15. Dementia data and analysis: a guide for health professionals

Dementia data and analysis: a guide for health professionals Dementia data and analysis: a guide for health professionals - GOV.UK GOV.UK uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve government digital services. Any data collected is anonymised. By continuing to use this site, you agree to our use of cookies. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Register by 26 November to vote in the General (...) Election on 12 December. Guidance Dementia data and analysis: a guide for health professionals Explains how commissioners and health professionals can use data and analysis for decisions about dementia services and interventions. Published 29 September 2016 Last updated 5 November 2019 — From: Contents Public Health England ( brings together a wide range of publicly available data on dementia. It can be used to understand the prevalence of dementia and how it is prevented and diagnosed locally. It also

2019 Public Health England

16. Effect of Collaborative Dementia Care via Telephone and Internet on Quality of Life, Caregiver Well-being, and Health Care Use: The Care Ecosystem Randomized Clinical Trial (Abstract)

Effect of Collaborative Dementia Care via Telephone and Internet on Quality of Life, Caregiver Well-being, and Health Care Use: The Care Ecosystem Randomized Clinical Trial Few health systems have adopted effective dementia care management programs. The Care Ecosystem is a model for delivering care from centralized hubs across broad geographic areas to caregivers and persons with dementia (PWDs) independently of their health system affiliations.To determine whether the Care Ecosystem (...) , California, and Omaha, Nebraska. Of 2585 referred or volunteer PWD-caregiver dyads in California, Iowa, or Nebraska, 780 met eligibility criteria and were enrolled. A total of 512 PWD-caregiver dyads were randomized to receive care through the Care Ecosystem and 268 dyads to receive usual care. All eligible PWDs had a dementia diagnosis; were enrolled or eligible for enrollment in Medicare or Medicaid; and spoke English, Spanish, or Cantonese. Analyses were intention-to-treat.Telephone-based

2019 EvidenceUpdates

17. Diagnosis and Management of Dementia: Review. (Abstract)

Diagnosis and Management of Dementia: Review. Worldwide, 47 million people live with dementia and, by 2050, the number is expected to increase to 131 million.Dementia is an acquired loss of cognition in multiple cognitive domains sufficiently severe to affect social or occupational function. In the United States, Alzheimer disease, one cause of dementia, affects 5.8 million people. Dementia is commonly associated with more than 1 neuropathology, usually Alzheimer disease with cerebrovascular (...) pathology. Diagnosing dementia requires a history evaluating for cognitive decline and impairment in daily activities, with corroboration from a close friend or family member, in addition to a thorough mental status examination by a clinician to delineate impairments in memory, language, attention, visuospatial cognition such as spatial orientation, executive function, and mood. Brief cognitive impairment screening questionnaires can assist in initiating and organizing the cognitive assessment. However

2019 JAMA

18. Weighted Blankets for Dementia Care in Long-Term Care: Clinical Effectiveness, Cost-Effectiveness, and Guidelines

Weighted Blankets for Dementia Care in Long-Term Care: Clinical Effectiveness, Cost-Effectiveness, and Guidelines Weighted Blankets for Dementia Care in Long-Term Care: Clinical Effectiveness, Cost-Effectiveness, and Guidelines | CADTH.ca Find the information you need Weighted Blankets for Dementia Care in Long-Term Care: Clinical Effectiveness, Cost-Effectiveness, and Guidelines Weighted Blankets for Dementia Care in Long-Term Care: Clinical Effectiveness, Cost-Effectiveness, and Guidelines (...) Last updated: January 24, 2019 Project Number: RB1301-000 Product Line: Research Type: Devices and Systems Report Type: Summary of Abstracts Result type: Report Question What is the clinical effectiveness of using weighted blankets for patients with dementia in long-term care? What is the cost-effectiveness of using weighted blankets for patients with dementia in long-term care? What are the evidence-based guidelines associated with the use of weighted blankets for patients with dementia in long

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review

19. Non-Invasive Brain Stimulation Techniques for the Treatment of the Behavioural and Psychological Symptoms of Severe Dementia: Clinical Effectiveness

Non-Invasive Brain Stimulation Techniques for the Treatment of the Behavioural and Psychological Symptoms of Severe Dementia: Clinical Effectiveness Non-Invasive Brain Stimulation Techniques for the Treatment of the Behavioural and Psychological Symptoms of Severe Dementia: Clinical Effectiveness | CADTH.ca Find the information you need Non-Invasive Brain Stimulation Techniques for the Treatment of the Behavioural and Psychological Symptoms of Severe Dementia: Clinical Effectiveness Non (...) -Invasive Brain Stimulation Techniques for the Treatment of the Behavioural and Psychological Symptoms of Severe Dementia: Clinical Effectiveness Last updated: April 24, 2019 Project Number: RA1027-000 Product Line: Research Type: Devices and Systems Report Type: Reference List Result type: Report Question What is the clinical effectiveness of non-invasive brain stimulation techniques for the behavioural and psychological symptoms of dementia? Key Message Ten systematic reviews (seven with meta-analyses

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review

20. Electroconvulsive Therapy for the Treatment of the Behavioural and Psychological Symptoms of Dementia: A Review of Clinical Effectiveness and Guidelines

Electroconvulsive Therapy for the Treatment of the Behavioural and Psychological Symptoms of Dementia: A Review of Clinical Effectiveness and Guidelines Electroconvulsive Therapy for the Treatment of the Behavioural and Psychological Symptoms of Dementia: A Review of Clinical Effectiveness and Guidelines | CADTH.ca Find the information you need Electroconvulsive Therapy for the Treatment of the Behavioural and Psychological Symptoms of Dementia: A Review of Clinical Effectiveness and Guidelines (...) Electroconvulsive Therapy for the Treatment of the Behavioural and Psychological Symptoms of Dementia: A Review of Clinical Effectiveness and Guidelines Last updated: May 22, 2019 Project Number: RC1114-000 Product Line: Research Type: Devices and Systems Report Type: Summary with Critical Appraisal Result type: Report Question What is the clinical effectiveness of electroconvulsive therapy for the treatment of the behavioural and psychological symptoms of dementia in older adults? What is the safety

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review